These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34850597)

  • 61. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The use of echocardiography left ventricular filling pressures in hypertensive patients with heart failure and preserved systolic function in a North Africa unit day].
    Ali-Tatar Chentir N; Tir Y; Ouabdesselam L; Chentir MT
    Ann Cardiol Angeiol (Paris); 2016 Jun; 65(3):197-202. PubMed ID: 27180566
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
    Selvaraj S; Klein I; Danzi S; Akhter N; Bonow RO; Shah SJ
    Am J Cardiol; 2012 Jul; 110(2):234-9. PubMed ID: 22502900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis.
    Teramoto K; Santos M; Claggett B; John JE; Solomon SD; Kitzman D; Folsom AR; Cushman M; Matsushita K; Skali H; Shah AM
    PLoS Med; 2020 Oct; 17(10):e1003361. PubMed ID: 33057391
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of Left Ventricular Stroke Volume on Incident Heart Failure in a Population With Preserved Ejection Fraction (from the Strong Heart Study).
    De Marco M; Gerdts E; Mancusi C; Roman MJ; Lønnebakken MT; Lee ET; Howard BV; Devereux RB; de Simone G
    Am J Cardiol; 2017 Apr; 119(7):1047-1052. PubMed ID: 28159195
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Chronic heart failure].
    Hradec J
    Cas Lek Cesk; 2015; 154(6):260-8. PubMed ID: 26750621
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk stratifying asymptomatic left ventricular systolic dysfunction in the community: beyond left ventricular ejection fraction.
    Burocchi S; Gori M; Cioffi G; Calabrese A; Canova P; De Maria R; Grosu A; Fontana A; Iacovoni A; Ferrari P; Volpe M; De Biase L; Parati G; Gavazzi A; Senni M
    Eur Heart J Cardiovasc Imaging; 2020 Dec; 21(12):1405-1411. PubMed ID: 31808506
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs.
    Silver MA; Pisano C
    Congest Heart Fail; 2003; 9(3):127-32. PubMed ID: 12826770
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Screening for asymptomatic heart failure with preserved ejection fraction in mongolian population at high risk.
    Unurjargal T; Khorloo C; Ulziisaikhan G; Sodovsuren N; Khasag A
    Kardiologiia; 2020 Mar; 60(4):86-90. PubMed ID: 32394862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The natural history of preclinical diastolic dysfunction: a population-based study.
    Vogel MW; Slusser JP; Hodge DO; Chen HH
    Circ Heart Fail; 2012 Mar; 5(2):144-51. PubMed ID: 22278404
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects.
    Gong FF; Campbell DJ; Prior DL
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1504-1519. PubMed ID: 29216977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Associations of Left Ventricular Structure and Function With Blood Pressure in Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.
    Wei FF; Xue R; Thijs L; Liang W; Owusu-Agyeman M; He X; Staessen JA; Dong Y; Liu C
    J Am Heart Assoc; 2020 Aug; 9(15):e016009. PubMed ID: 32750310
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.
    Betti I; Castelli G; Barchielli A; Beligni C; Boscherini V; De Luca L; Messeri G; Gheorghiade M; Maisel A; Zuppiroli A
    J Card Fail; 2009 Jun; 15(5):377-84. PubMed ID: 19477397
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
    Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K
    Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B-type natriuretic peptide.
    Popescu BA; Popescu AC; Antonini-Canterin F; Rubin D; Cappelletti P; Piazza R; Ginghina C; Dimulescu D; Beladan CC; Nicolosi GL
    Echocardiography; 2007 Nov; 24(10):1035-43. PubMed ID: 18001356
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
    Weiner RB; Baggish AL; Chen-Tournoux A; Marshall JE; Gaggin HK; Bhardwaj A; Mohammed AA; Rehman SU; Barajas L; Barajas J; Gregory SA; Moore SA; Semigran MJ; Januzzi JL
    Eur J Heart Fail; 2013 Mar; 15(3):342-51. PubMed ID: 23132825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.